NE

Neola Medical ABFNSE Neola Medical Stock Report

Last reporting period 31 Dec, 2023

Updated 22 Oct, 2024

Last price

Market cap $B

0.005

Micro

Exchange

FNSE - First North Sweden

NEOLA.ST Stock Analysis

NE

Uncovered

Neola Medical AB is uncovered by Eyestock quantitative analysis.

Market cap $B

0.005

Dividend yield

Shares outstanding

55.686 B

Neola Medical AB engages in the research, development, and commercialization of medical devices. The company is headquartered in Lund, Skane. The company went IPO on 2020-10-02. The firm's business concept is to commercialize the Company's medical technology product for continuous lung monitoring based on the patented GASMAS (Gas in Scattering Media Absorption Spectroscopy) technology. Neola Medical's technology equipment aims for continuous monitoring of the lungs of premature babies. The primary purpose of Neola Medical is to support neonatal intensive care with NEOLA, a medical device that can offer continuous lung monitoring and real-time alerts about life-threatening complications using new technology that measures lung volume changes and oxygen concentration.

View Section: Eyestock Rating